Germany female infertility market is expected to witness a significant growth rate during the forecast period. The country has a major market share for the female infertility market in Europe due to increasing cases of infertility. As per CIA the mean age of mother at the time of first birth is 29.4 years. It has increased by 2 years in 2016 as compared to 2013. In 2017, out of the total population, 41 million are female and 39% of the female is the age of 25-54 years, age in which female population mostly faces the problems of infertility. Due to the high proportion of females in this age criteria, the problem of infertility is expected to be witnessed in the region during the forecast period.
Moreover, the subsidization of IVF treatments in Germany further contributes to the growth of the market. According to the European Society of Human Reproduction and Embryology (ESHRE) in 2017, National policy in Germany reimburses 50% of IVF/ICSI costs for up to three cycles which in turn, is expected to drive the IVF industry and hence female infertility treatment market.
To Request a Sample of our Report on Germany Female infertility Market: https://www.omrglobal.com/request-sample/germany-female-infertility-market
Germany female infertility market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.
Some of the major players operating in Germany female infertility market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in Germany market.
(Get 15% Discount on Buying this Report)
A full Report of Germany Female infertility Market is Available @ https://www.omrglobal.com/industry-reports/germany-female-infertility-market
Germany Female Infertility Diagnosis and Treatment Market Segmentation
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By Diagnosis
- Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others (Laparoscopy)
By End-User
- Hospitals and Clinics
- Homecare
- Pathology and Diagnostic Centers
Company Profiles
- Bayer AG
- Merck KGaA
- Pfizer
- Church & Dwight Co., Inc.
- Vitrolife
- Cook Medical, Inc.
- GlaxoSmithKline Plc.
- Merck KGaA
- Esco Group
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
